Exploring Pharmaceutical Innovation and Investment in Europe

This chapter explores the significant funding gap in pharmaceutical innovation between the United States and Europe, stressing the importance of health sovereignty. It also examines how UK government policies affect investment decisions by companies like AstraZeneca and the broader implications for the sector's economic growth.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app